
Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek S.A.
Manufacture of pharmaceutical preparations
Overview
Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - is a Polish manufacturer of pharmaceuticals, dietary supplements, and products for both pharmacy and non-pharmacy markets. Their brands include IBUM, DIH, Ulgix, and NaturKaps, and they have been committed to high-quality pharmaceutical products since the 1980s.
- ul. Kwiatkowskiego 9, 55-011 Siechnice
- Aleje Jerozolimskie 154, 02-326 Warszawa
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $2,357,230 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 83 days late). All were audited by a statutory auditor.
- 202503/07/2026
- 202426/06/2025
- 202325/06/2024
- 202229/06/2023
- 202106/10/2022
- 202025/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News

10th Hasco-Lek Independence Run with a Moustache

Hasco-Lek partner of the XXII Health Market Forum

Hasco-Lek at the XXII Autumn Pharmaceutical Symposium

Hasco-Lek awarded at the 35th anniversary Gala of the Silesian Chamber of Pharmacists

Hasco-Lek supports the Food Bank in Wrocław

Hasco Group joins the "Childhood without Violence" campaign
Industry
Websites
The company has 6 websites. All of them run on WordPress.
- hasco-lek.plInspiruje nas Twoje zdrowie i komfort życia | Hasco-LekWordPress 7.1ElementorYoast SEOWWPMLLLiteSpeed
- hascovircontrol.plHascovir® – pozbądź się opryszczki z Hascovir control MAXWordPress 7.1ElementorYoast SEOLLiteSpeed
- melnabol.plMel na ból - lek przeciwbólowy i przeciwzapalnyWordPress 7.1ElementorYoast SEOLLiteSpeed
Trademarks
The company currently holds no active trademarks with the Polish Patent Office. 44 marks have expired or were not registered. The first mark was filed in 1995.
| Mark | Protected until | |
|---|---|---|
| Hascoderm lipocontrol (word) | – | |
| Mark without a word element (figurative) | – | |
| LORAST (word) | – | |
| Ulgix regulacja | – | |
| BluMAG jedyny | – |
Job offers
The company has its own careers page: hasco-lek.pl/kariera/dlaczego-warto-z-nami-pracowac.
Authorized Representatives
Manner of representation
For submitting declarations of will on behalf of the company and signing documents, each member of the management board is authorized to act independently.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Profesjonalna Obsługa Pojazdów Hancars sp. z o.o. | 6,671,083.20 USD | 99.9852% | ||
Haston City Hotel sp. z o.o. | 3,510,399.78 USD | 99.9654% | ||
HB Invest sp. z o.o. | 2,536,655.86 USD | 33.9691% |
Bank accounts
Registered as a VAT taxpayer on 2005-11-01.
29 1090 1522 0000 0001 1907 2566
22 1020 5226 0000 6102 0019 8580
37 1600 1462 1737 2768 7000 0001
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $2.1M$2,079,872 |
Buildings and premises | $27M$26,970,192 |
Public aid
21 public aid cases recorded, with a total value of $4,834,430.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 7, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Agencja Rozwoju Regionalnego Arleg S.A. | |
| Nov 28, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezydent Wrocławia | |
| Nov 25, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Dolnośląska Agencja Rozwoju Regionalnego S.A. |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2017-10-01 | Implementation of process innovation at Przedsiębiorstwo Produkcji Farmaceutycznej Hasco-Lek S.A. in the form of computer-assisted interpretation of analytical and process data to define the design space during R&D work on new products, through the purchase of specialist equipment and software | $282.8K$282,774 | Regional Operational Programme for the Lower Silesian Voivodeship 2014-2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| Waste generation | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Adamed Pharma S.A. | $541,927,181.76 | adamed.com.pl | ||
| Biofarm sp. z o.o. | $143,422,260.45 | biofarm.pl | ||
| Zentiva Polska sp. z o.o. | $134,295,523.17 | zentiva.pl | ||
| Olimp Laboratories sp. z o.o. | $123,984,672.64 | olimp-labs.pl | ||
| Farmak International sp. z o.o. | $101,647,142.16 | farmakinternational.pl | ||
| Synoptis Pharma sp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| Polfarmex S.A. | $73,543,379.32 | polfarmex.pl | ||
| Zakłady Farmaceutyczne Colfarm S.A. | $27,692,749.78 | colfarm.pl | ||
| Exim Pharma sp. z o.o. | $24,694,130.27 | eximpharma.eu | ||
| Aristo Pharma sp. z o.o. | $22,775,627.72 | aristo-pharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-10-08 | PKD change (Removed: 10.89.Z, 72.11.Z, 72.19.Z; Added: 10.86.Z, 10.89.A, 72.10.Z) | |
| 2004-03-30 | Share capital increase (10,000,000.00 PLN → 329,944,036.00 PLN) | |
| 2003-10-28 | Name change ("hasco-Investment" → "przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek") | |
| 2002-05-14 | Share capital increase (1,500,000.00 PLN → 10,000,000.00 PLN) | |
| 2001-09-21 | Address change (Olsztyńska 5, 51-423, Wrocław → Żmigrodzka 242e, 51-131, Wrocław) |
FAQ
Last updated: 2026-10-08